Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer

INTRODUCTION: Metastatic breast cancer seriously harms women’s health and is currently the tumour type with the highest mortality rate in women. Recently, the combinatorial therapeutic approaches that integrate anti-cancer drugs and genetic agents is an attractive and promising strategy for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Jialang, Chen, Siqi, Hu, Ye, Yang, Fan, Huo, Qin, Xie, Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954039/
https://www.ncbi.nlm.nih.gov/pubmed/33727809
http://dx.doi.org/10.2147/IJN.S278724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954039/
https://www.ncbi.nlm.nih.gov/pubmed/33727809
http://dx.doi.org/10.2147/IJN.S278724

Ejemplares similares